Genmab AS

Genmab AS Tax Expense

The Income Tax Expense of Genmab AS (GMAB) as of Nov 22, 2026 is 241.19 M USD. In the previous year, Income Tax Expense was 1.32 B USD — a change of -81.73% (lower).

Tax Expense

241.19 MUSD

YoY

-81.73%

Last updated:

Income Tax Expense of Genmab AS is 2025 241.19 M USD. Income Tax Expense of Genmab AS was 2024 1.32 B USD. It decreases by -81.73% lower compared to the previous year.

The Genmab AS Tax Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tax Expense
Date
Tax Expense
Jan 1, 2018
139.83 M USD
Jan 1, 2019
693.00 M USD
Jan 1, 2020
1.15 B USD
Jan 1, 2021
961.00 M USD
Jan 1, 2022
1.49 B USD
Jan 1, 2023
1.29 B USD
Jan 1, 2024
1.32 B USD
Jan 1, 2025
241.19 M USD
The Genmab AS Tax Expense history
YEARTax ExpenseYoY
241.19 MUSD-81.73%
1.32 BUSD+2.72%
1.29 BUSD-13.93%
1.49 BUSD+55.36%
961.00 MUSD-16.14%
1.15 BUSD+65.37%
693.00 MUSD+395.60%
139.83 MUSD-451.06%
-39.83 MUSD-29.95%
-56.86 MUSD+849.85%
-5.99 MUSD+51.54%
-3.95 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

Income Tax Expense of Genmab AS is 241.19 M USD in 2025.

Income Tax Expense of Genmab AS changed from 1.32 B USD to 241.19 M USD, representing a -81.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Income Tax Expense Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's Genmab AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Genmab AS

All Key Metrics — Genmab AS